[1]
“Fibrin sealant versus autologous Platelet-Rich Plasma for prevention of seroma after breast cancer surgery: An exploratory randomized controlled trial”, JOC, vol. 24, no. 1s, pp. 156–166, Feb. 2025, doi: 10.66838/.